We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

71 hedge funds and large institutions have $795M invested in Cullinan Oncology in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

1% more funds holding

Funds holding: 70 → 71 (+1)

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1.55% less ownership

Funds ownership: 75.66% → 74.11% (-1.6%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

39% less capital invested

Capital invested by funds: $1.3B → $795M (-$504M)

Holders
71
Holders Change
+1
Holders Change %
+1.43%
% of All Funds
1.24%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
18
Increased
22
Reduced
19
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIG
American International Group
New York
+$37.6M
2
DM
Deerfield Management
New York
+$32.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.3M
4
IC
Ikarian Capital
Texas
+$9.06M
5
Franklin Resources
Franklin Resources
California
+$8.89M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$30.2M
2
APM
Avidity Partners Management
Texas
-$29.5M
3
VC
Vivo Capital
California
-$10.4M
4
BI
BVF Inc
California
-$9.66M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
76
Wellington Management Group
Massachusetts
– -$6.44M -154,539 Closed
CAM
77
Cormorant Asset Management
Massachusetts
– -$6.25M -150,000 Closed
FCM
78
Farallon Capital Management
California
– -$5.21M -125,000 Closed
Canada Pension Plan Investment Board
79
Canada Pension Plan Investment Board
Ontario, Canada
– -$2.67M -64,000 Closed
CCM
80
CAAS Capital Management
New York
– -$2.5M -60,000 Closed
SSA
81
Schonfeld Strategic Advisors
New York
– -$2.02M -48,373 Closed
JGC
82
J. Goldman & Co
New York
– -$1.77M -42,539 Closed
Alyeska Investment Group
83
Alyeska Investment Group
Illinois
– -$1.04M -25,000 Closed
LCM
84
Laurion Capital Management
New York
– -$875K -21,000 Closed
TD Asset Management
85
TD Asset Management
Ontario, Canada
– -$781K -18,739 Closed
PNC Financial Services Group
86
PNC Financial Services Group
Pennsylvania
– -$306K -7,356 Closed
VOYA Investment Management
87
VOYA Investment Management
Georgia
– -$228K -5,466 Closed
Bank of Montreal
88
Bank of Montreal
Ontario, Canada
– -$14K -399 Closed
1 2 3
4

CGEM Hedge Fund Activity: Q2 2021 in Review

71 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q2 2021, worth a combined $795M — down 39% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CGEM positions and 17 closed out — a net gain of 1 holder — while 22 added to existing stakes and 19 trimmed.

The largest buyer was American International Group, adding an estimated $37.6M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $30.2M sold.

  • 71 institutional investors held Cullinan Oncology (CGEM) as of Q2 2021, up from 70 in Q1 2021.
  • Funds reported $795M of Cullinan Oncology stock for Q2 2021, down 39% quarter-over-quarter.
  • 18 funds opened new Cullinan Oncology positions in Q2 2021 and 17 closed out, a net change of +1 holder.
  • The largest Cullinan Oncology buyer in Q2 2021 was American International Group, an estimated $37.6M added.
  • The largest Cullinan Oncology seller in Q2 2021 was T. Rowe Price Associates, an estimated $30.2M sold.

Based on aggregated 13F filings for Q2 2021.